Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Rimm Huh"'
Publikováno v:
Annals of Pediatric Endocrinology & Metabolism, Vol 25, Iss 2, Pp 92-96 (2020)
Purpose Adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis and occurs in children between 10 to 18 years old, during periods of growth spurts and puberty changes. In patients with central precocious puberty (CPP), due to early
Externí odkaz:
https://doaj.org/article/70f73751daf34e00a6fd80243313537b
Publikováno v:
Annals of Pediatric Endocrinology & Metabolism, Vol 20, Iss 2, Pp 106-109 (2015)
We report a 13-year-old girl with Graves disease, who showed an increased level of serum creatine kinase (CK) accompanied by myalgia after methimazole (MMI) treatment. This patient developed muscular pain two weeks after MMI administration, along wit
Externí odkaz:
https://doaj.org/article/57fbe40cc5f34f9fb20c5979ab5d0f1c
Autor:
Aram Yang, Yeon Hee Lee, Soon Young Nam, Yu Ju Jeong, Yechan Kyung, Rimm Huh, Jieun Lee, Younghee Kwun, Sung Yoon Cho, Dong-Kyu Jin
Publikováno v:
Annals of Pediatric Endocrinology & Metabolism, Vol 20, Iss 1, Pp 40-45 (2015)
PurposePrader-Willi syndrome (PWS) is a well-known genetic disorder, and microdeletion on chromosome 15 is the most common causal mechanism. Several previous studies have suggested that various environmental factors might be related to the pathogenes
Externí odkaz:
https://doaj.org/article/12797dedc87e49cfb2afb12db1e291cb
Publikováno v:
Annals of Pediatric Endocrinology & Metabolism
Annals of Pediatric Endocrinology & Metabolism, Vol 25, Iss 2, Pp 92-96 (2020)
Annals of Pediatric Endocrinology & Metabolism, Vol 25, Iss 2, Pp 92-96 (2020)
Purpose Adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis and occurs in children between 10 to 18 years old, during periods of growth spurts and puberty changes. In patients with central precocious puberty (CPP), due to early
Autor:
Min Jung Kwak1, Rimm Huh2, Jinsup Kim2, Hyung-Doo Park3, Sung Yoon Cho2, Dong-Kyu Jin2 jindk@skku.edu
Publikováno v:
BMC Medical Genetics. 8/12/2016, Vol. 17, p1-5. 5p.
Publikováno v:
Respirology. 21:1068-1074
Background and objective High-dose chemotherapy (HDCT) followed by autologous haematopoietic stem cell transplantation (HSCT) is widely used in paediatric cancer patients, but few data about noninfectious interstitial lung disease (ILD) following thi
Autor:
Duk Kyung Kim, Byung Koo Yoon, Hye Sun Hyun, Dong Kyu Jin, Dong-Yun Lee, DooSeok Choi, Rimm Huh
Publikováno v:
Journal of Korean Medical Science
This study evaluated the efficacy of a stepwise regimen of estradiol valerate for height control in girls with Marfan syndrome. Eight girls with Marfan syndrome who had completed estrogen treatment for height control were included. Estradiol valerate
Publikováno v:
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
BMC Medical Genetics, Vol 19, Iss 1, Pp 1-2 (2018)
BMC Medical Genetics
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
BMC Medical Genetics, Vol 19, Iss 1, Pp 1-2 (2018)
BMC Medical Genetics
Background Mucopolysaccharidosis I (MPS I) is an autosomal recessive lysosomal storage disorder caused by a lack of the lysosomal enzyme α-L-iduronidase (IDUA). To date, more than 200 IDUA mutations have been reported. However, only a few types of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de3f1bafce3945bd389ff56dc2591b12
Autor:
Su Jin Kim, Sung Yoon Cho, Sung Won Park, Jinsup Kim, Dong-Kyu Jin, Ah-Ra Ko, Hyun-Hee Kwak, Rimm Huh, Young Bae Sohn
Publikováno v:
Molecular Pharmaceutics. 12:3759-3765
The current recombinant human growth hormone (rhGH) therapy requires daily subcutaneous (sc) injections, which results in poor patient compliance, especially in young children. To reduce the dosing frequency, we generated a chimeric protein of rhGH a
Publikováno v:
Molecular Genetics and Metabolism. 114:156-160
Idursulfase beta (Hunterase®) has been used for enzyme replacement therapy (ERT) of patients with mucopolysaccharidosis II (MPS II, Hunter syndrome) aged 6 years or older since 2012 in Korea. The objective of this study was to evaluate the safety an